Fig. 2
From: Evaluation of the theranostic potential of [64Cu]CuCl2 in glioblastoma spheroids
A Viability of spheroids derived from U87, U373, T98G, and RA cell lines, evaluated after eight days of [64Cu]CuCl2 exposure, using the APH assay. Results are presented as the fold change to each cell line's respective untreated control. Data are presented as mean values ± S.E.M. of 2 to 4 independent assays. B Survival fraction of spheroid-derived cells from U87, U373, T98G, and RA cell lines after 3 h of [64Cu]CuCl2 exposure, presented as a fraction of the untreated control, determined through the clonogenic assay. Data are presented as mean values ± S.E.M of 3 to 5 independent assays. **p < 0.01, ***p < 0.001, ****p < 0.0001